MondayNov 02, 2020 10:29 am

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces Q3-2020 Results, Notes Significant Strides on Multiple Initiatives

Energy Fuels (NYSE American: UUUU) (TSX: EFR), a leading producer of uranium in the United States, on Friday reported its financial results for the quarter ended September 30, 2020. In addition, Energy Fuels will host a webcast to review the results at 4:00 p.m. ET on Tuesday, November 3, 2020. Interested parties may join by dialing 1-888-390-0541 (toll free in the U.S. and Canada) and accessing the viewer-controlled webcast slides via the following link: https://ibn.fm/WrPyC. “Energy Fuels made significant strides in the last quarter on our uranium, rare earths and other initiatives,” the company’s president and CEO Mark S. Chalmers…

Continue Reading

MondayNov 02, 2020 9:41 am

QualityStocksNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRTC) Secures New, Repeat BolaWrap(R) Orders, Appoints New Director of International Sales

Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, announced receipt of new and repeat domestic orders for BolaWrap(R) products and accessories. According to the update, the company has received numerous recent orders from domestic law enforcement agencies and expects to complete shipping next month. In addition, the company today announced the appointment of Jags Gill as its new director of international sales. Based out of London, Gill brings over 15 years of experience in senior sales management across global law enforcement and security sectors. In his new role, Gill will be responsible for managing and driving international sales…

Continue Reading

FridayOct 30, 2020 2:20 pm

QualityStocksNewsBreaks – Pure Extracts Technologies Inc. Leveraging Growing Acceptance of ‘Nature’s Miniature Pharmaceutical Factories’

Pure Extracts, a private, plant-based extraction company, is leveraging growing acceptance by mainstream science and the general public to further develop and commercialize functional and medicinal mushroom products on a global scale. World-renowned mycologist Paul Stamets describes mushrooms as “nature’s miniature pharmaceutical factories” (https://ibn.fm/wbYSa). Studied extensively for their various health benefits, current research suggests different varieties of mushrooms may help to improve memory (https://ibn.fm/KUHQ3), mental cognition (https://ibn.fm/dNuo4) and to alleviate the symptoms of depression (https://ibn.fm/YCMQK). Further, “Psychedelic” varieties such as psilocybin – or “magic mushrooms” – are increasingly being studied for possible medical benefits in treating depression, anxiety, PTSD, bipolar disorder, Alzheimer’s disease and…

Continue Reading

FridayOct 30, 2020 2:04 pm

QualityStocksNewsBreaks – GreenBox POS (GRBX) Files for Nasdaq Capital Market Uplisting

GreenBox (OTCQB:GRBX), an emerging financial technology company leveraging proprietary blockchain security to build customized payment solutions, today announced that it has submitted its application to uplist the company's common stock on the Nasdaq Capital Market ("Nasdaq"). If approved, the company would begin trading under the "GBOX" ticker it has reserved. "We are very pleased the recent round of financing has put us in a position to execute on our growth strategy and work towards a major milestone by submitting our application to uplist to Nasdaq. We believe being listed on a national exchange will increase corporate visibility, improve liquidity and…

Continue Reading

FridayOct 30, 2020 1:49 pm

QualityStocksNewsBreaks – Oncocyte Corporation (NYSE American: OCX) Named Among the 2020 Best Places to Work in Orange County

Oncocyte (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, on Wednesday announced it has been named as one of the 2020 Best Places to Work in Orange County. Oncocyte ranked number four out of 40 in the medium-size company category. A project of the Orange County Business Journal and Best Companies Group, the awards program was created in 2009. “Great technologies and great strategies don’t do great things; great people accomplish great things,” said Ron Andrews, CEO of Oncocyte. “While our world of molecular diagnostics…

Continue Reading

FridayOct 30, 2020 1:34 pm

QualityStocksNewsBreaks – Rritual Mushrooms Inc. Recognized at ECRM’s Whole Body & Mind Wellness Program

Rritual, a plant-based consumer wellness brand, was selected as runner up for the Buyers Choice Award at last week’s virtual ECRM program. According to an article on Business Wire, Rritual’s Reishi Relax Elixir was selected for the award among dozens of entries evaluated by retail buyers. “Retail buyers selected Rritual for the award because our packaging, design and formulation stood out amongst the dozens of products they evaluated,” said David Kerbel, CEO of Rritual. “Their stamp of approval on our product reinforces what we know: that Rritual products will capture the attention of shoppers on shelves and in e-comm, supporting…

Continue Reading

FridayOct 30, 2020 1:18 pm

QualityStocksNewsBreaks – Grey Cloak Tech Inc. (GRCK) Announces Q3 Filing, Increased Sales and Revenue

Grey Cloak Tech (OTC: GRCK) (soon to be Healthy Extracts Inc. pending a corporate name change), a company engaged in proprietary development of natural plant-based formulations and sales and distribution of cardiovascular and neuro products, today announced the filing of its Form 10-Q for the third quarter ended Sept. 30, 2020. In addition, the company also announced its financial results for the nine months ended Sept. 30, 2020, and provided an update on the progress of its corporate strategy. Among the highlights, the company reported revenue increases of 99% to $1,140,657 and a 46% gross profit increase to $697,479 for…

Continue Reading

FridayOct 30, 2020 12:58 pm

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSX.V: ISGI) (OTC: IGSTF) Opens BOP for Business, Extends Coverage to Vital US Sector

InsuraGuest Technologies (TSX.V: ISGI) (OTC: IGSTF), an innovative insurtech leader, has extended its general liability coverage to a vital sector of the U.S. economy—small businesses—with the launch of its business owner policy (“BOP”) portal. InsureThePeople.com enables small business owners and operators of a wide range of enterprises to purchase insurance protection, underwritten by Crum & Forster, for a variety of special needs. The BOP comes at a crucial time as risks for small business owners have increased dramatically. A recent article discussing the portal reads, “The Insure the People website incorporates many of the beneficial features of InsuraGuest’s insurtech platform.…

Continue Reading

FridayOct 30, 2020 12:54 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Sells Remaining MD Ownership Stake

SRAX (NASDAQ: SRAX), an innovative fintech solutions provider that unlocks data and insights for publicly traded companies through its SaaS platform, Sequire, today announced that it has sold its remaining interest in the SRAX MD asset. “Our SEQUIRE platform is rapidly growing and we are focused on the continued expansion of this business. We believe that selling the MD ownership stake at this time reinforces our goal of being 100% focused on providing our platform and services to public companies,” said Christopher Miglino, founder and CEO of SRAX. “This capital will be effective in helping us accelerate growth. This asset…

Continue Reading

FridayOct 30, 2020 12:23 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Launch of New Branding for Upcoming Combination Clinical Trials

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for cancer and diabetes patients, today announced the launch of new branding for its upcoming oncology clinical trials. The trials combine Genprex’s lead drug candidate, REQORSA(TM) (quaratusugene ozeplasmid), with AstraZeneca’s Tagrisso(R) (osimertinib), which received U.S. Food and Drug Administration (“FDA”) Fast Track Designation earlier this year, as well as the combination of REQORSA with Merck’s Keytruda(R) (pembrolizumab), for the treatment of non-small cell lung cancer (“NSCLC”). “We are enthusiastically preparing for our upcoming clinical trials and are excited to launch the adoption of this branding,” said Rodney Varner,…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered